Small Cell Lung Carcinoma
Combined small-cell lung carcinoma
7
Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics
15
Current role of surgery in small cell lung carcinoma
6
Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
13
Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma
10
Cetuximab and biomarkers in non-small-cell lung carcinoma
11
Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
7
Favorable Response of Advanced Superior Sulcus Non-Small Cell Lung Carcinoma to Gefitinib for 11 years complicated by Interval Development of Small Cell Carcinoma of the Lung.
10
Clinical potential of necitumumab in non-small cell lung carcinoma
11
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases
13
Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature
5
Endoplasmic reticulum Ca2+-homeostasis is altered in small and non-small cell lung cancer cell lines
7
Studying combined effects of chemotherapy and radiotherapy on blood cell counts in lung cancer patients
8
A Brief Review on Lung Cancer
8
A study of Expression of Epidermal growth factor receptor (EGFR) in Lung Cancers.
152
Triple synchronous primary lung cancer: a case report and review of the literature
6
Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer
8
Small cell carcinoma of the kidney: a case report and analysis of data from the Surveillance, Epidemiology, and End Results registry
6
Pathological transition as the arising mechanism for drug resistance in lung cancer
13
<p>Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis</p>
13